Alignment Healthcare, Inc. ALHC

Insider Buys alert about insiders buying in the last 12 month

Financial statements are limited to most recent four years or quarters for non-powerpack users

Ten years worth of data (where available), most important trends and XLS exports are available for our Powerpack users.

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '17
Net Income (0.98) (128.07) (148.17) (149.64) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Depreciation & Amortization 30.95 25.78 18.01 19.34 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Non Cash Items (Other) 64.45 76.17 68.96 90.43 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Accounts Receivable Change (100.11) (34.28) (26.95) (34.38) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Accounts Payable Change 184.78 84.39 35.26 44.25 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Change in payables and accrued liability 19.45 4.36 0.23 17.35 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Change in other assets and liabilities (58.61) 6.42 (6.51) (32.78) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Other operating activities ‡‡‡
Operating Cash Flow 139.93 34.77 (59.19) (45.43) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Capital expenditures (26.71) (41.40) (35.99) (23.77) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Aquisitions 1.07 (4.04) ‡‡‡‡‡
Long-Term Investments Change (Net) 10.67 80.60 (111.27) (0.40) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Other investing activities (5.20) ‡‡‡‡‡
Investing cash flow (14.97) 39.19 (147.26) (28.22) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Repayment/Issuance of Debt (Net) 165.00 21.82 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Equity Repurchase (Common, Net) 18.07 0.16 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Other financial activities (0.03) (9.13) 0.11 (5.23) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Financing cash flow 18.04 156.03 0.11 16.59 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Change in Cash 142.99 229.99 (206.34) (57.05) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Beginning Cash 434.94 204.95 411.30 468.35 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Ending Cash 577.94 434.94 204.95 411.30 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Stock Based Compensation 62.08 71.13 66.84 81.72 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Dividends Paid (Common) 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡
Net Cash/Marketcap 0.00 0.00 0.00 0.00 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Assets Liabilities Change (Total) 45.51 60.89 2.03 (5.55) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Investments Change (Net) 10.67 80.60 (111.27) (0.40) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Issuance/Purchase of Shares 18.07 0.16 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue per Employee 2.14 1.61 1.19 1.38 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
In millions of $ except per-share values · columns are period end dates